20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Cetilistat: Chemical Properties and Research Applications

At NINGBO INNO PHARMCHEM CO.,LTD., we pride ourselves on supplying critical chemical compounds that fuel scientific advancement. Cetilistat, identified by its CAS number 282526-98-1, is one such compound, noted for its significant role in pharmaceutical research, particularly in the area of obesity treatment. Understanding its chemical properties is key to appreciating its utility.

Cetilistat is characterized as a white crystalline powder, a stable form that is conducive to storage and handling in research environments. Its chemical structure is designed to specifically interact with and inhibit pancreatic lipase, an enzyme essential for fat digestion. This precise interaction is the basis for its efficacy in studies related to anti-obesity drug mechanisms. Researchers often rely on the consistent quality of high purity cetilistat powder to ensure the validity of their experimental results.

The application of Cetilistat extends across various facets of pharmaceutical research. It serves as a crucial tool in the investigation of pancreatic lipase inhibitor research, allowing scientists to explore the downstream effects of enzyme inhibition on metabolic health. This makes it an indispensable drug discovery research compound for those aiming to develop new therapeutic agents for metabolic disorders.

The development of effective treatments for obesity requires a deep understanding of the underlying physiology. Cetilistat contributes to this by providing a tangible example of how modulating fat absorption can impact body weight. This is fundamental to weight management drug development. NINGBO INNO PHARMCHEM CO.,LTD. supports these efforts by ensuring a reliable supply of this important pharmaceutical chemical.

For professionals engaged in cetilistat for obesity treatment studies, or any research requiring specific lipase inhibition, the chemical integrity of the compound is paramount. Our commitment to quality assurance means that researchers can depend on the purity and specifications of the Cetilistat we provide, enabling them to focus on their scientific objectives without concern for material variability.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Role of Cetilistat in Advancing Obesity Management Strategies

Next: The Future of Obesity Treatment: Insights from Cetilistat Research

All Rights Reserved